1. Home
  2. TOVX vs FORM Comparison

TOVX vs FORM Comparison

Compare TOVX & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • FORM
  • Stock Information
  • Founded
  • TOVX 2001
  • FORM 1993
  • Country
  • TOVX United States
  • FORM United States
  • Employees
  • TOVX N/A
  • FORM N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • FORM Semiconductors
  • Sector
  • TOVX Health Care
  • FORM Technology
  • Exchange
  • TOVX Nasdaq
  • FORM Nasdaq
  • Market Cap
  • TOVX 3.5M
  • FORM 3.0B
  • IPO Year
  • TOVX 2006
  • FORM N/A
  • Fundamental
  • Price
  • TOVX $1.14
  • FORM $42.88
  • Analyst Decision
  • TOVX Strong Buy
  • FORM Buy
  • Analyst Count
  • TOVX 1
  • FORM 8
  • Target Price
  • TOVX $6.00
  • FORM $55.38
  • AVG Volume (30 Days)
  • TOVX 96.3K
  • FORM 819.8K
  • Earning Date
  • TOVX 11-12-2024
  • FORM 02-05-2025
  • Dividend Yield
  • TOVX N/A
  • FORM N/A
  • EPS Growth
  • TOVX N/A
  • FORM N/A
  • EPS
  • TOVX N/A
  • FORM 1.72
  • Revenue
  • TOVX N/A
  • FORM $742,279,000.00
  • Revenue This Year
  • TOVX N/A
  • FORM $17.59
  • Revenue Next Year
  • TOVX N/A
  • FORM $8.39
  • P/E Ratio
  • TOVX N/A
  • FORM $24.89
  • Revenue Growth
  • TOVX N/A
  • FORM 12.31
  • 52 Week Low
  • TOVX $1.14
  • FORM $37.21
  • 52 Week High
  • TOVX $17.00
  • FORM $63.63
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 36.15
  • FORM 52.33
  • Support Level
  • TOVX $1.23
  • FORM $41.93
  • Resistance Level
  • TOVX $1.21
  • FORM $50.79
  • Average True Range (ATR)
  • TOVX 0.07
  • FORM 2.14
  • MACD
  • TOVX 0.01
  • FORM 0.17
  • Stochastic Oscillator
  • TOVX 0.00
  • FORM 22.53

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

Share on Social Networks: